Coveo grabs $35 mln Series D

By Iris Dorbian — 3 months ago

Coveo, a provider of intelligent search solutions, has raised $35 million in Series D funding. IQ Venture Capital led the round with participation from return backers that include Tandem Expansion Fund, BDC Capital, Propulsion Ventures SEC, Fonds de solidarité FTQ and Coveo CEO Louis Tetu. PRESS RELEASE QUEBEC–(Marketwired – November 05, 2015) – Coveo, a recognized […]


Milestone Pharma raises $17 mln

By Luisa Beltran — 8 months ago

Milestone Pharmaceuticals Inc. said Monday that it closed a $17 million series B financing led by Domain Associates. All of Milestone’s existing investors including Fonds de solidarité FTQ , Pappas Ventures, BDC Capital, GO Capital and iNovia Capital participated in the round. Montreal-based Milestone Pharma is a clinical stage cardiovascular company.


Milestone Pharmaceuticals picks up $17 mln

By Iris Dorbian — 8 months ago

Canada-based Milestone Pharmaceuticals, a drug developer focused on cardiovascular diseases, has raised $17 million in Series B funding. Domain Associates led the round with participation from other investors that included Fonds de solidarité FTQ, Pappas Ventures, BDC Capital, GO Capital and iNovia Capital. In conjunction with the funding, Domain’s Debra Liebert has been added to Milestone’s board of directors.


Thrasos Innovation raises $21 mln

By Luisa Beltran — 10 months ago

Thrasos Innovation has raised a $21 million financing round from investors including the Fonds de solidarité FTQ, BDC Venture Capital and SR One. Thrasos, of Montreal, is biotech focused on developing therapies to treat kidney disease.


Coveo Secures Funding Led by Tandem

By Angela Sormani — 3 years ago

Search technology provider Coveo has secured $18 million in funding led by Canadian late-stage technology investment firm Tandem Expansion Fund. All major existing investors also participated in the round, including BDC Venture Capital, Propulsion Ventures SEC and Fonds de solidarité FTQ.


Milestone Pharma Inks $13M

5 years ago

Milestone Pharmaceuticals Inc., a Montreal-based cardiovascular drug development company, has raised $13 million in fresh capital. Pappas Ventures, the Business Development Bank of Canada and GO Capital co-led the round. Fonds de solidarité FTQ, iNovia Healthcare Ventures and Fonds Bio-Innovation also participated. The money will be used for continued development. As a result of the round, Eric Linsley, managing partner of Pappas Ventures; Scott Weiner, senior principal at Pappas Ventures; and Dominic Jaikaran, principal at BDC Health Venture Fund, will join Milestone’s board.